SENSEX NIFTY

Glenmark Pharmaceuticals

Jul 29, 2016 at 14:33 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on August 12, 2016 to consider and approve the Company's Unaudited Financial Statements for the First Quarter ended June 30, 2016 (Q1).
Jul 27, 2016 at 11:26 | Source: PTI
"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Potassium Chloride Extended Release Tablets USP, 10mEq (750 mg) and 20mEq (1500mg)," it said in a BSE filing.
Jul 27, 2016 at 08:33 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the USFDA for Potassium Chloride Extended-Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg).
Jul 26, 2016 at 09:52 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Ltd has informed BSE that the Company has announces the successful closure of its USD 200 mn Reg S USD Bond. The bond was oversubscribed 8 times.
Jul 26, 2016 at 07:46 | Source: PTI
Investment banking sources told PTI that the issue was so successful that the orderbook touched 12 times the issue size at USD 2.4 billion, helping the company make good bargain on pricing.
Jul 25, 2016 at 11:38 | Source: PTI
"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.5 percent," it said in a BSE filing.
Jul 25, 2016 at 08:44 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the USFDA for Triamcinolone Acetonide Ointment USP, 0.5 percent.
Jul 21, 2016 at 08:23 | Source: CNBC-TV18
ITC | HDFC Bank | Kotak Mahindra Bank | L&T Infotech | Wipro Hindustan Zinc | KPIT Technologies | KEI Industries | Nucleus Software | Bharat Seats | IIFL Holdings | UltraTech Cement | HPCL | Nevyeli Lignite | Ambuja Cements and VRL Logistics are stocks, which are in the news today.
Jul 20, 2016 at 17:50 | Source: PTI
The approval granted by the USFDA to three domestic firms for generic rosuvastatin calcium tablets are for strengths of 5 mg, 10 mg, 20 mg and 40 mg.
Jul 20, 2016 at 16:47 | Source: CNBC-TV18
Neeraj Deewan of Quantum Securities is of the view that Glenmark Pharma may test Rs 900 in next 5-6 months.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

15495 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

15495 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

15495 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

15495 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd 2014

BSE/NSE Announcer

Platinum Member

15495 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th 2014

adviserbola

Platinum Member

2270 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th 2014

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th 2014

Amrita Gaba

New Member

409 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th 2014

BSE/NSE Announcer

Platinum Member

15495 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th 2014

News across the web »
Jun 24, 2016 at 11:50 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.